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Objective: The surgical treatment of valvular heart disease has changed significantly in the past decade with more
mitral valves being repaired and tissue valves implanted in the aortic position. The National Inpatient Sample was
used to document national trends of primary isolated aortic and mitral valve surgical procedures.
Methods: Subjects were adult patients who had an isolated aortic or mitral valve repair or replacement in the
United States. Estimated institution cost and total billed charges data were provided by the Centers for Medicare
and Medicaid Services.
Results: From 1998 to 2005, an estimated 330,000 aortic or mitral valve procedures were performed in the United
States (repair, n¼ 46,342; replacement, n¼ 287,989). Since 1998, annual valve repair or replacement procedures
increased 186.6% and 12.6%, respectively. Aortic valve repair or replacement procedures increased 102.5% and
28.0%, respectively, with an increased percentage for repairs from 2.0% in 1998 to 3.1% in 2005. Mitral valve
repair procedures increased from18.9% in 1998 to 45.8% in 2005, with mitral replacements decreasing 17.2%
over the same period. Since 1998, the total hospital billed charges for aortic valve repair procedures increased
80.6% and aortic valve replacement procedures 90.4%; mitral valve repair procedures increased from 37.8%,
replacement 42.0%. Annual increases in estimated institution cost increased for both aortic and mitral procedures
on average 8% to 9%.
Conclusion: During the last decade the practice of valve surgery has changed significantly. The surgical treat-
ment for mitral disease has transitioned to primarily one of repair, not replacement, with the use of bioprostheses
more than doubled. For the aortic position, the primary procedure remained valve replacement with bioprosthesis
being the valve of choice. Regardless of valve disease, institutional costs and charges for the surgical treatment
have greatly outpaced physician reimbursement.
ACQUIRED CARDIOVASCULAR DISEASEOne in 3 American adults has cardiovascular disease.1 In
2005, over 6.9 million inpatient cardiovascular surgeries
and procedures were performed in the United States (4.1
million men; 2.9 million women) with open heart surgeries
accounting for 10%.1 Valvular heart diseases were among
the most predictable causes of heart failure; recent data com-
piled by the American Heart Association indicate that the
mortality due to valvular heart disease in the United States
is estimated to be 20,000 patients per annum. The number
of direct deaths related to aortic valve disease is estimated
at 12,548.2 Total hospital discharges for aortic valve disease
are estimated to be 48,000 patients. Estimates for direct mor-
tality related to mitral valve disease are 2542 persons, with
total mentioned mortality estimated at 6600 persons. An es-
timated 38,000 patients are discharged with mitral valve
disease.1
Recent reports have demonstrated the cost-effectiveness
and decreased rates of perioperative outcomes of valve sur-
gery in the elderly,3,4 although details regarding annual
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This field has evolved dramatically with the increased utili-
zation of a new generation of heart valves, more aggressive
repair techniques, and improved results. In this report, data
on trends of isolated aortic and mitral valve procedures
during the period of 1998 to 2005 were obtained from the
National Inpatient Sample (NIS).
METHODS
Data Source
The data related to aortic and mitral valve surgery were obtained through
the Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare
Research and Quality, NIS.7 The NIS is the largest all-payer inpatient care
database in the United States, containing data from approximately 8 million
hospital stays each year. The 2005 NIS database contains all discharge data
from 1054 hospitals located in 37 states, approximating a 20% stratified
sample of US community hospitals. The sampling frame for the 2005 NIS
database is a sample of hospitals that comprises approximately 90% of
all hospital discharges in the United States. The NIS is the only national hos-
pital database containing charge information on all patients, regardless of
payer, including persons covered byMedicare, Medicaid, private insurance,
and the uninsured patients.
Aortic and Mitral Valve Surgical Procedures
We analyzed the 1998 to 2005 NIS public data file to determine changes
in the pattern of use for both isolated aortic and mitral valve procedures. The
NIS presents up to 15 procedure codes with the primary International Clas-
sification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
procedure codes listed as the first procedure code. We abstracted codes
from coding positions 1 to 3 as either primary aortic or mitral primaryrgery c June 2009
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CC ¼ Cost to charge
HCUP ¼ Healthcare Cost and Utilization
Project
ICD-9-CM ¼ the International Classification of
Diseases, Ninth Revision, Clinical
Modification
LOS ¼ length of stay
NIS ¼ National Inpatient Sample
STS ¼ Society of Thoracic Surgeons
ICD-9-CM procedures by the following: any occurrences of an aortic (3521,
3522, 3511) or mitral procedure (3523, 3524, 3512) listed in the positions 1
to 3. Procedures were further restricted to only isolated aortic and mitral
valve procedures by eliminating patients with any procedure code of
361x (bypass anastomosis for heart revascularization), 376x (implantation
of heart or other circulatory assist device), 381 (endarterectomy), or 377x
(insertion, revision, replacement, removal of pacemaker leads). Patients
with implanted pacemakers were included (378x). Congenital anomalies
were ICD-9 codes 746.3 and 746.4. Patients aged<18 years were removed
from the analysis. The NIS provides no data regarding repeat procedures.
Financial Charge Data
The NIS contains data on total billed charges for each hospital. This
charge information represents the amount that hospitals billed for services
but does not reflect how much hospital services actually cost or the specific
amounts that hospitals received in payment. Cost to charge (CC) data were
only available for the years 2001 to 2004. Group average CC is a weighted
average for the hospitals in the group (defined by state, urban/rural, investor-
owned/other, and number of beds) and uses the proportion of group beds as
the weight for each hospital. Estimated institution cost data were calculated
by multiplying HCUP supplied CC ratios against total charges. Cost will
tend to reflect the actual costs of a case, and charges represent what the hos-
pital billed for each case.
Statistics
Continuous data are presented as mean  standard error. Categorical
data are presented as frequency and percent. Standard errors were calculated
by taking into account the sampling scheme and sample discharge weights.8
Hierarchical multilevel analyses were conducted using mixed-effects
models on the natural log of total billed charges using a random intercepts
and fixed slopes approach. The natural log was chosen to reduce skewness.
All analyses were conducted in SAS (Version 9.1, Cary, NC). This analysis
was exempt from Institutional Review Board review.
RESULTS
Between 1998 and 2005, approximately 340,000 surgical
procedures to address aortic or mitral valve heart pathology
were performed in the United States (valve repair, n ¼
46,342; replacement, n¼ 287,989) with replacement proce-
dures over 6 times more prevalent (Table 1). Among valve
procedures, the proportion of annual valve procedures that
were repair increased 187% compared with a 13% increase
among valve replacement procedures (Table 1, Figure 1).
ICD codes referring to congenital anomalies accounted for
2.3% of repairs and 4.9% of replacements, respectively.The Journal of Thoracic and CValve insufficiency accounted for 90.3% and 93.7% of re-
placements and repairs; stenosis accounted for 9.7% and
6.3% of replacements and repairs.
Between 1998 and 2005, the use of mechanical valves de-
creased from 83.2% to 62.8% with a simultaneous increase
in tissue valves from 16.8% to 37.2%. During this period,
use of tissue valves among female patients increased from
18.5% to 38.0%, whereas among male patients, tissue
valves increased from 14.1% to 36.2%.
Aortic Valve Procedures
From 1998 to 2005, the total volume of aortic valve repair
and replacement procedures increased 102.5% and 28.0%,
respectively (Table 2). No changes in average age were ob-
served from 1998 (repair: 56.6  42.2; replacement: 64.5 
33.6) to 2005 (repair: 53.4  39.8; replacement: 64.9 
32.3). As a percentage of annual aortic procedures per-
formed, aortic repairs increased from 2.0% (n ¼ 439) in
1998 to 3.1% (n ¼ 889) in 2005. Female patients repre-
sented 40.6% of all aortic valve surgeries performed (repair,
40.0%; replacement, 40.7%). From 1998 to 2005, a small
annual decrease in the proportion of women having aortic
valve surgical procedures was observed (1998, 41.9%;
2005, 39.1%). ICD codes referring to congenital anomalies
accounted for 7.9% and 6.8% of aortic valve repair and re-
placement procedures, respectively. Of the congenital aortic
valve repairs, 93.8% were due to valve insufficiency and
6.2% from valve stenosis; for aortic replacements, 90.4%
were insufficiency and 9.3% stenosis.
Over the study period, the use of tissue valves in aortic
valve replacement doubled from 26.7% in 1998 to 50.2%
in 2005 (Figure 1). Since 1999, aortic valve replacement
has primarily been performed with the use of tissue valves
(1999, 50.0%; 2005, 71.4%) among patients aged 75 years
or greater; all other age groups remained predominantly me-
chanical but the proportion decreased annually with patients
aged 51 to 75 years, approaching tissue usage rates observed
among older patients (Table 3). No gender differences in the
proportion of aortic tissue valve use were observed over the
study period. The implantation of tissue valve doubled over
the study period (women: 1998, 29.5% and 2005, 53.2%;
men: 1998, 24.8%, and 2005, 48.2%). The use of tissue
valves for patients aged< 65 years tripled from 11.4% in
1998 to 31.4% in 2005 compared with a doubling among
patients age 65 years (1998, 37.8%; 2005, 64.6%). Oper-
ative mortality for patients receiving a tissue valve was
higher overall (4.6% vs 3.7%) but appeared more related
to early in the study period (1998, death vs. no death
5.1% vs 3.6%; 2005, 3.1% vs 2.9%). From 1998 to
2005, hospital deaths for aortic valve repairs decreased
20.7% (9.2% vs 7.3%) compared with 25.0% decrease in
mortality for aortic valve replacements (4.0% vs 3.0%).
The length of stay (LOS) for patients following aortic
valve procedure was frequently observed to be 6 to 10ardiovascular Surgery c Volume 137, Number 6 1423
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the proportion of LOS less than 5 days increased from
27.0% in 1998 to 33.3% in 2005. The percentage of aortic
replacements with a LOS less than 5 days increased from
25.3% in 1998 to 29.4% in 2005.
TABLE 1. Annual change in isolated aortic and mitral valve
procedures: National Inpatient Sample, 1998 to 2005
Procedure
Year Repair Replacement
1998 3025 (8.5) 32,573 (91.5)
1999 4316 (11.7) 32,673 (88.3)
2000 4717 (11.6) 35,964 (88.4)
2001 5869 (13.2) 38,631 (86.8)
2002 6033 (14.3) 36,175 (85.7)
2003 7477 (15.9) 39,450 (84.1)
2004 6236 (14.8) 35,844 (85.2)
2005 8669 (19.1) 36,678 (80.9)
Change (%) 186.6 12.6
Total 46,342 287,989
Change (%), Relative from 2005 to 1998.Mitral Valve Procedures
From 1998 to 2005, the total volume of mitral valve repair
and replacement procedures increased 201.2% and 17.2%,
respectively (Table 2). No changes in average age were ob-
served from 1998 (repair: 58.0  33.1; replacement: 62.0 
32.0) to 2005 (repair: 58.6  32.1; replacement: 62.1 
31.1). As a percentage of annual mitral procedures, valve
repair increased from 18.9% (n ¼ 2586) in 1998 to 45.8%
(n ¼ 7790) in 2005. Female patients represented 54.3% of
mitral procedures (repair, 42.6%; replacement, 59.8%).
ICD codes referring to congenital anomalies accounted for
1.6% and 0.7% of mitral valve repair and replacement pro-
cedures, respectively. Of the congenital mitral valve repairs,
70.2% were due to valve insufficiency and 29.8% from
valve stenosis; for aortic replacements, 69.8% were insuffi-
ciency and 30.1% stenosis.
Over the study period, the use of tissue valves in mitral
valve replacement doubled from 16.9% in 1998 to 36.5%
in 2005 (Figure 1). Since 2003, mitral valve replacement
has primarily been performed with the use of tissue valves
(2003, 52.2%; 2005, 62.3%) among patients aged 75 yearsFIGURE 1. Annual changes in primary valve repair and procedure rates.
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Aortic Mitral
Repair Replacement Repair Replacement
1998 439 (2.0) 21,459 (98.0) 2586 (18.9) 11,114 (81.1)
1999 541 (2.4) 21,892 (97.6) 3775 (25.9) 10,781 (74.1)
2000 591 (2.4) 24,186 (97.6) 4127 (26.0) 11,778 (74.0)
2001 711 (2.6) 26,568 (97.4) 5158 (29.9) 12,063 (70.1)
2002 524 (2.0) 25,579 (98.0) 5509 (34.2) 10,596 (65.8)
2003 754 (2.7) 27,724 (97.3) 6722 (36.4) 11,726 (63.6)
2004 710 (2.6) 26,181 (97.4) 5526 (36.4) 9664 (63.6)
2005 889 (3.1) 27,471 (96.9) 7790 (45.8) 9207 (54.2)
Change (%) 102.5 28.0 201.2 17.2
Change (%), Relative from 1998 to 2005.or greater (Table 3). On average, less than one-quarter of mi-
tral replacement valves in patients were tissue, and one-third
were for patients between the ages of 51 and 75. No gender
differences in the proportion of mitral tissue valve use were
observed over the study period.
Tissue valve use doubled for both genders (women: 1998,
18.9% and 2005, 37.8%; men: 1998, 13.9% and 2005,34.8%). The implantation rate of tissue valves for patients
aged< 65 years tripled from 6.2% in 1998 to 21.1% in
2005 and doubled among patients age  65 years (1998,
27.4; 2005, 52.7). Operative mortality for patients receiving
a tissue valve was higher overall (9.1% vs 5.6%) but ap-
peared more related to years early in the study period
(1998, death vs no death: 11.1% vs 5.6%; 2005, 6.6% vsA
C
DTABLE 3. Characteristics of primary aortic and mitral valve procedures from 1998 to 2005
Aortic Mitral
Repair Replacement Repair Replacement
1998 2005 1998 2005 1998 2005 1998 2005
Female, n (%) 197 (44.8) 293 (33.3) 8983 (41.9) 10780 (58.1) 1159 (44.8) 3090 (39.9) 6938 (62.4) 5352 (58.1)
Age (y)
18–25 24 (5.5) 71 (16.1) 197 (0.9) 267 (1.0) 48 (1.9) 137 (1.8) 106 (1.0) 130 (1.4)
26–50 134 (30.4) 71 (8.1) 3721 (17.3) 4343 (15.8) 715 (27.7) 2177 (27.9) 2312 (20.8) 1807 (19.6)
51–75 211 (48.0) 291 (33.1 12,064 (56.2) 15,271 (55.6) 1582 (61.2) 4427 (56.8) 6813 (61.3) 5580 (60.6)
75þ 71 (8.1) 416 (47.4) 5477 (25.5) 7590 (27.6) 241 (9.9) 1050 (13.5) 1882 (16.9) 1691 (18.4)
Elective* — 453 (51.6) — 18443 (67.2) — 6077 (78.1) — 5591 (60.7)
Hospital death 40 (9.2) 64 (7.3) 851 (4.0) 822 (3.0) 55 (2.1) 115 (1.5) 725 (6.5) 453 (4.9)
Payer
Medicare 198 (45.1) 262 (29.8) 11,174 (52.1) 15,126 (55.1) 961 (37.2) 2819 (36.2) 5123 (46.1) 4653 (50.5)
Medicaid 27 (6.1) 96 (11.0) 1025 (4.8) 1318 (4.8) 138 (5.3) 386 (5.0) 924 (8.3) 803 (8.7)
Private 190 (43.2) 435 (50.0) 7898 (36.8) 9804 (35.7) 1316 (50.9) 4280 (54.9) 4325 (38.9) 3257 (35.6)
Self-pay 21 (4.7) 56 (6.4) 459 (2.1) 519 (1.9) 26 (1.0) 134 (1.7) 277 (2.5) 244 (2.7)
No charge 4 (0.9) 5 (0.6) 13. (0.1) 76 (0.3) 17 (0.6) 9 (0.1) 26 (0.2) 37.8 (0.4)
Other 0 (0.0) 25 (2.9) 891 (4.2) 629 (2.3) 129 (4.9) 163 (2.1) 441 (4.0) 213 (2.3)
Region
Northeast 99 (22.5) 122 (14.5) 4736 (22.1) 6363 (24.0) 617 (23.9) 1946 (25.9) 2465 (22.2) 1757 (19.7)
Midwest 170 (38.6) 364 (43.1) 6213 (29.0) 6721 (25.4) 629 (24.3) 2162 (28.8) 3204 (28.8) 2050 (23.0)
South 122 (27.7) 170 (20.2) 6944 (32.4) 6473 (24.4) 935 (36.1) 1794 (23.9) 3772 (33.9) 3003 (33.6)
West 49 (11.1) 188 (22.3) 3566 (16.6) 6956 (26.2) 405 (15.7) 1600 (21.3) 1672 (15.0) 2123 (23.8)
Teaching hospital
Yes 352 (80.1) 672 (76.5) 16,257 (75.8) 17,806 (64.8) 2052 (79.4) 5356 (68.8) 8665 (78.0) 6157 (66.9)
No 87 (19.9) 206 (23.5) 5203 (24.2) 9664 (35.2) 533 (20.6) 2434 (31.2) 2448 (22.0) 3050 (33.1)
Length of stay (d)
0–5 118 (27.0) 293 (33.3) 5426 (25.3) 8086 (29.4) 990 (39.3) 3407 (43.7) 2026 (18.2) 1537 (16.7)
6–10 189 (43.0) 294 (33.4) 10,093 (47.0) 12,151 (44.2) 1069 (41.3) 2915 (37.4) 4897 (44.1) 3802 (41.3)
11þ 132 (30.0) 293 (33.3) 5940 (27.7) 7235 (26.3) 527 (20.4) 1468 (18.8) 4191 (37.7) 3868 (42.0)
*Available only from 2002.
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DTABLE 4. Trends in total billed charges and estimated institution cost for primary aortic and mitral valve procedures from 2001–2005
Aortic Mitral
Repair Replacement Repair Replacement
Mean SE Mean SE Mean SE Mean SE
Total estimated
billed charges
1998 76,423 12,087 62,055 1841 51,179 2589 97,907 5381
2005 138,005 13,240 118,128 4859 70,520 2334 139,039 5840
% increase 80.6 90.4 37.8 42.0
Annual institution cost
2001 36,785 3555 34,480 818 28,405 1143 39,217 1272
2002 56,426 8455 37,564 1163 32,874 1224 42,734 1408
2003 40,930 2761 42,864 1421 35,411 1501 50,026 2000
2004 51,540 5407 42,189 1484 38,321 2398 54,427 2254
2005 55,206 5104 45,594 1547 38,642 1695 53,562 2206
% increase 50.1 32.2 36.0 36.6
Cost data only available for years 2001–2005. SE, Standard error;% increase, relative from 2001 to 2005.4.0%). From 1998 to 2005, hospital deaths for mitral valve
repairs decreased 28.7% (2.1% vs 1.5%) compared with
24.6% (6.5% vs 4.9%) for mitral valve replacements.
Among mitral valve procedures, a 6- to 10-day LOS was
most frequently observed (41.4%). Among mitral valve re-
pair patients, the proportion of LOS less than 5 days de-
creased from 41.3% in 1998 to 37.4% in 2005. The
percentage of mitral replacements with an LOS less than 5
days decreased from 18.2% in 1998 to 16.7% in 2005.
Institution Cost and Total Billed Charges
Over the study period, total billed charges for aortic valve
procedures increased $62,341 $1867 in 1998 to $118,762
 $4815 (90.5%, Table 4). Total billed charges for aortic
valve procedures at least doubled from 1998 to 2005, with
aortic replacements showing the greatest increase (90.4%;
repair, 80.6%). From 2001 to 2005, annual institution costs
for aortic valve procedure increased 50.1% for repairs and
32.2% for replacements (Table 4, Figure 2).
Between 2001 and 2005, institution cost for the replace-
ment with aortic tissue valves increased on average 36.4%
compared with 27.0% for mechanical valves (tissue: 2001,
$34,996 and 2005, $47,723; mechanical: 2001, $34,121
and 2005, $43,348). Until recently, the average increased in-
stitution cost of implanting an aortic tissue valve versus ame-
chanical valve was only 2.5%; in 2005, the cost differential
was 10.1%.
Over the study period, total billed charges for mitral valve
procedures increased from $66,865  $2131 to $119,966 
$5235 (79.4%, Table 4). Total billed charges for mitral pro-
cedures at least doubled from 1998 to 2005, with mitral re-
pairs increasing the least (37.8%). From 2001 to 2005,
institution cost increased for mitral repair and replacement
procedures 36.0% and 36.6%, respectively (Table 4, Fig-
ure 2). The cost of both mitral repair and replacement proce-
dures increased annually on average 8.0% to 8.5%.1426 The Journal of Thoracic and Cardiovascular SuBetween 2001 and 2005, mitral valve replacement with
tissue valves cost increased on average 35.7% compared
with 34.3% for mechanical valves (tissue: 2001, $42,313
and 2005, $57,405; mechanical: 2001, $38,158 and 2005,
$51,259). During the study period, the estimated institution
cost of a mitral valve repair, regardless of type, increased on
average 12.9%.
Hierarchical Regression
We examined the impact of individual hospital variance
on procedure type (repair vs replacement) and aortic versus
mitral procedure and the natural log(total billed charges) us-
ing mixed-effects models. Thirty-nine percent of the total
variance in log(total billed charges) was related to hospital
variation (intraclass correlation coefficient). Among aortic
procedures, log(total billed charges) for repairs was signifi-
cantly increased (6.1%, P< .001) over replacement proce-
dures after adjusting for individual hospital variation.
Among mitral procedures, log(total billed charges) for re-
pairs were significantly increased (78.1%, P<.001) over re-
placement procedures after adjusting for individual hospital
variation.
DISCUSSION
In this report, we present data and trends from the NIS on
aortic and mitral valve procedure performed over the last
decade. Significant findings worth noting are the relatively
striking lack of changes over the last decade in the percent-
age of aortic valve replacements as a proportion of all per-
formed aortic valve procedures. More than 95% of the
aortic valve procedures performed during the mid 1990s
were for replacement and remained so during the mid 2000s.
The most significant change in the practice of aortic valve
surgery is the opposite trend in the percentage of mechanical
and tissue valve implantation. In the mid 1990s, the majority
of the replaced aortic valves were mechanical prosthesis, andrgery c June 2009
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FIGURE 2. Estimated institution cost trends of primary aortic and mitral valve procedures from 2001–2004.A
C
Dthe majority of implants in 2005 were tissue valves. This
trend may relate to extensive publications regarding the
long-term results of aortic valve replacement and, more spe-
cifically, comparisons between tissue and mechanical pros-
thesis showing comparable outcome with a slightly lower
valve-related complication rates, especially in patients over
the age of 60 years.9-11
Mitral valve procedures present a completely opposite
trend. The use of mitral valve replacement over the last de-
cade declined from 80% of all mitral valve procedures to
a current use of approximately 50%, with figures from dif-
ferent institutions that suggest higher repair rate for certain
mitral valve pathologies with very good durability.12,13
This trend represents a significant change in the cardiac sur-
gery practice for mitral valve surgery, and it may be related
to extensive publications in support of the mitral valve repair
over replacement both in the perioperative phase and in late
follow-up.14,15 Trends toward decreases in mitral valve re-
placement procedures may largely be explained due to in-
creased understanding of the mitral valve pathophysiology
leading to greater surgical proficiency, comparable perioper-
ative outcomes,16-21 and long-term survival18,21,22 and an in-
creased focus on patient quality of life by decreased use of
warfarin.23-25
Last, data suggest a steady 8% to 9% annual increase in
hospital cost for both aortic and mitral procedures. When
total billed charges were analyzed using hierarchical regres-
sion to adjust for hospital variation within HCUP, approxi-
mately 39% of total variance (aortic: 41%; mitral: 37%)
in billed charges between procedure type or valve type
was due to individual hospitals. This suggests that although
Medicare reimbursements for aortic and valve procedures
remains standardized, individual hospital billing is not.
Although total billed charges for aortic and valve procedures
have at least doubled since 1998, Medicare physician reim-
bursement fees for vascular and general surgery have
decreased.26,27 Data from our own practice suggest a 14%
decrease in reimbursement for aortic valve replacements,The Journal of Thoracic and Cwith a subsequent 10% and 16% decrease in mitral valve re-
placements and mitral valve repair reimbursement over the
same period of time.
Published data from the Society of Thoracic Surgeons
(STS) National Adult Cardiac Surgery Database suggest
a 629% increase in aortic valve replacement procedures
from 1990 (n ¼ 1246) to 1997 (n ¼ 9095).25 During the
same period, mitral valve replacement procedures increased
600% (1990, n¼ 657; 1997, n¼ 4605) and mitral valve re-
pair procedures increased 796% (1990, n ¼ 223; 1997, n ¼
2000). When stratified by gender, the proportion of female
patients having aortic valve replacement increased 2.5%
percentage points (1990, 40.3%; 1997, 42.8%). The propor-
tion of female patients having mitral valve replacement
increased slightly (1990, 61.4%; 1997, 61.8%) but de-
creased with mitral valve repair (1990, 59.8%; 1997,
40.8%).28 Published STS data from spring 2007 (unpub-
lished participant data) showed observed operative mortality
rates for isolated aortic and mitral replacement in the year
2006 were 3.1% and 5.6%, respectively, with reported
STS observed mortality rates for mitral valve repair of
1.9%. With the exception of aortic repair mortality rates
(not reported at the STS), the STS and HCUP rates are com-
parable. Differences in aortic valve repair rates may be the
HCUP sampling strategy actually capturing data from one
of the few centers that continue to perform aortic valve re-
pairs and may not be reflective of the overall success rates
found within the STS. The STS database remains the largest
cardiac surgery database in the world and, as such, remains
an excellent source for cardiac surgery clinical data. An in-
creasing number of institutions use the STS database, al-
though participation remains voluntary. As it currently
exists, the STS national database offers a greater level of
clinical detail than the HCUP, but the STS database is not
a nationally probabilistic sample of cases and participation
without financial data.
Although the STS data are helpful in viewing trends, in-
terpretation must be made with caution. The STS is theardiovascular Surgery c Volume 137, Number 6 1427
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volume is most likely due to increased participation by num-
ber of centers. The NIS by contrast uses different sources
and methods to capture data; however, the data are well cor-
related with previous publications using the STS Adult Car-
diac Surgery Registry and those in Europe. Savage and
colleagues29 and Keogh and associates30 reported mitral
valve repair rate of 42.4% and 35% for the United States
and Britain, respectively, at the year 2000.
These changes in trends might be attributed to several im-
portant but individually separate factors relating to the com-
plexity of valve procedures. For aortic valve procedures, the
complexity of the valve and underlying root structure does
not lend itself to repair in most cases. In addition, when at-
tempted, repair procedures have not demonstrated compara-
ble perioperative31 or late outcomes.32 However, recent
developments in aortic root remodeling with preservation
of the native valve can minimize anticoagulation therapies
and minimize valve-related complications.32-34
LIMITATIONS
Although the NIS represents the largest publicly available
sample of inpatient hospitalization in the United States,
some limitations are present. Despite rigorous attempts to
use advanced probabilistic models to generate randomly
sampled institutions, only 20% of nationwide institutions
were sampled, and we cannot guarantee that institutions
serving cardiac needs were completely represented. To our
knowledge, the NIS sampling design does not subsample
based on medical populations. Furthermore, as with any na-
tionally sampled data, some populations of disease and
procedure populations are undoubtedly underrepresented
due to variations in ICD-9-CM coding schemes and inter-
pretations. We feel this limitation is most likely minimal
as we restricted our analysis to primary aortic and mitral
valve procedures, both serious interventional procedures
that are highly unlikely to be miscoded or missed by insti-
tution coders altogether. CC ratios should be examined
with caution due to various differences in state reporting
mechanisms. Several states report individual participating
institution CC ratios, but several states only report state
average. Although this makes for a difficult state-by-state
comparison, overall national trends will be similar as indi-
vidual state methodologies remain constant. Strengths of
this database are its large size, representative quality, and
standardized methodology.
Although these national data suggest different patterns of
aortic and mitral valve procedure patterns over the last de-
cade, these data only reflect sampled US medical data.
Data may not reflect those of individual institutions. Further
studies reporting data from individual high-volume centers
would be helpful in confirming these trends and generating
more detailed data. Assuming these aortic and mitral valve
procedure trends continue, considerable effort should be1428 The Journal of Thoracic and Cardiovascular Surmade to ensure that allocation of hospital resources will be
commensurate.
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